{"meta":{"query_hash":"9a43560aa3fc","filters":{"venue":"Pharmaceutical Medicine"},"cohort_total":26,"direct_labels_cover":0,"predictions_cover":26,"exported":26,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9a43560aa3fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceutical+Medicine"},"results":[{"id":"W103748181","doi":"10.1007/bf03256813","title":"The Changing Face of Direct-to-Consumer Print Advertising","year":2010,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Georgia","keywords":"Advertising; Order (exchange); Quarter (Canadian coin); Business; Balance (ability); Over-the-counter; Content analysis; Medical prescription; Medicine","score_opus":0.3249485468030795,"score_gpt":0.5636868487637329,"score_spread":0.23873830196065338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W103748181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8361315,0.004564354,0.0005962461,0.102245666,0.011229743,0.00215232,0.00007158898,0.000374894,0.042633645],"genre_scores_gemma":[0.9857479,0.00067287235,0.00015415746,0.010646942,0.0012789059,0.00010102209,0.0000072492694,0.000044529683,0.0013464352],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607456,0.00057712046,0.0009065803,0.00053514383,0.00051931874,0.001387261],"domain_scores_gemma":[0.9945695,0.0027817853,0.00018557835,0.00048994686,0.0003059379,0.0016672586],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00359713,0.0003918199,0.0005648056,0.0002220353,0.00084445026,0.000019924788,0.0007699425,0.0005136483,0.0026213885],"category_scores_gemma":[0.0022690406,0.0002648045,0.00012635253,0.0008806416,0.0013491488,0.00011830096,0.00032109398,0.004294263,0.00027186377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014204524,0.0004329936,0.012416046,0.00028974644,0.00036999863,0.00007809739,0.0041219536,0.00010342916,0.4979517,0.017839048,0.0099487165,0.45502782],"study_design_scores_gemma":[0.001711495,0.00015173932,0.0013561137,0.00008587409,0.00024173135,0.00004917611,0.0005159032,0.0040312987,0.18328923,0.00038831806,0.8078801,0.00029903604],"about_ca_topic_score_codex":0.00002776478,"about_ca_topic_score_gemma":0.000026303802,"teacher_disagreement_score":0.7979314,"about_ca_system_score_codex":0.000062772204,"about_ca_system_score_gemma":0.00012441886,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W1883456152","doi":"10.1007/s40290-015-0106-6","title":"Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration; Hamilton Health Sciences Foundation","keywords":"Pharmacovigilance; Outreach; Adverse effect; Medicine; Event (particle physics); Adverse drug event; Medical emergency; Medical physics; Internal medicine","score_opus":0.4049343292784165,"score_gpt":0.5660667458406965,"score_spread":0.16113241656228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1883456152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911328,0.002892788,0.0006984327,0.0020735383,0.00027979133,0.0023611744,0.00009870075,0.000045023706,0.00041772588],"genre_scores_gemma":[0.9911389,0.00088596286,0.00033790187,0.00609798,0.00023920908,0.0010680124,0.00020226547,0.000021160506,0.000008653096],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9935713,0.0023702453,0.002699008,0.000419447,0.00042173732,0.0005182528],"domain_scores_gemma":[0.9924031,0.0043274304,0.0022770136,0.00049238023,0.00025102252,0.00024907332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015665453,0.00030337364,0.00077337964,0.00024869846,0.0004401551,0.0000091336515,0.00046273225,0.00013074638,0.000057797686],"category_scores_gemma":[0.0028977697,0.00019900699,0.00014397052,0.0013840692,0.00044135225,0.00026657947,0.00015239135,0.0019466601,0.000001222735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018787907,0.0052417587,0.7461389,0.00049544265,0.0016869686,0.00014882188,0.053272896,0.10488586,0.024204006,0.00043771806,0.00038813928,0.061220735],"study_design_scores_gemma":[0.011693636,0.0006555659,0.08458532,0.0002782641,0.010222785,0.00021936785,0.09118535,0.4024012,0.007132439,0.00058664207,0.3902364,0.0008030177],"about_ca_topic_score_codex":0.0012201163,"about_ca_topic_score_gemma":0.00034722587,"teacher_disagreement_score":0.66155356,"about_ca_system_score_codex":0.00017211257,"about_ca_system_score_gemma":0.0001302315,"threshold_uncertainty_score":0.8457378},"labels":[],"label_agreement":null},{"id":"W1980001858","doi":"10.1007/bf03256800","title":"Pharmaceutical Medicine in Switzerland","year":2010,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Specialty; Pharmaceutical industry; Medical education; Alternative medicine; Medicine; Pharmacy; Work (physics); Family medicine; Pharmacology; Engineering","score_opus":0.11966046848125413,"score_gpt":0.47484569267012305,"score_spread":0.35518522418886894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980001858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40488297,0.0072714253,0.0002502817,0.35829234,0.0046497015,0.0018826744,0.000011994336,0.0004343848,0.22232424],"genre_scores_gemma":[0.9685594,0.0031388549,0.00043233205,0.023370316,0.0036051946,0.00008008679,0.000026339294,0.00006832102,0.0007191659],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954117,0.00019225437,0.0011431711,0.0008574089,0.0011617581,0.0012337113],"domain_scores_gemma":[0.9956389,0.001743669,0.00015016457,0.0005331673,0.00021438199,0.0017196832],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021825098,0.0005780319,0.0012549267,0.00038684168,0.0001837965,0.000016536049,0.00035386966,0.00029237787,0.017042402],"category_scores_gemma":[0.0033229308,0.0003872398,0.00013442423,0.0010715516,0.0017985466,0.00023258767,0.0001954786,0.0035064835,0.0003754957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065773367,0.002356009,0.17659116,0.0011797833,0.00064340024,0.0032259515,0.0015890931,0.000003076937,0.4973449,0.01865738,0.049927358,0.24190454],"study_design_scores_gemma":[0.018104775,0.00080900587,0.03738028,0.00039054258,0.0008738847,0.0009553149,0.0002841397,0.0038531204,0.0053995107,0.0012371431,0.9302063,0.0005059627],"about_ca_topic_score_codex":0.0001822809,"about_ca_topic_score_gemma":0.000060303893,"teacher_disagreement_score":0.88027894,"about_ca_system_score_codex":0.00009782888,"about_ca_system_score_gemma":0.00009847723,"threshold_uncertainty_score":0.99985796},"labels":[],"label_agreement":null},{"id":"W1986483795","doi":"10.1007/s40290-015-0090-x","title":"Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordic Life Science Pipeline (Canada)","funders":"","keywords":"Big data; Medicine; Business; Pharmacology; Computer science; Data mining","score_opus":0.3911000808631966,"score_gpt":0.48831674186369234,"score_spread":0.09721666100049575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986483795","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020858876,0.0031510529,0.93628985,0.024845852,0.0016764671,0.00061648176,0.0000106443695,0.00034944084,0.012201325],"genre_scores_gemma":[0.8213534,0.00017406596,0.16761586,0.00618181,0.002714432,0.00007154123,0.00017669138,0.00006723391,0.0016449939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951909,0.00070775446,0.0007583891,0.0010362874,0.0012586573,0.0010480123],"domain_scores_gemma":[0.99492294,0.0022422967,0.00010539654,0.0014035655,0.0003039659,0.001021834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005778656,0.00035734224,0.0005465184,0.0004627808,0.00010278631,0.00010972385,0.002397119,0.00009562711,0.00012243153],"category_scores_gemma":[0.0067065475,0.00030725234,0.000045435983,0.0018958915,0.00028562482,0.00094151346,0.002334047,0.0008124532,0.00017485143],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068187155,0.0017662912,0.0067924852,0.0007206322,0.00023220977,0.0013818434,0.008023041,0.016577408,0.0026103535,0.21894002,0.03918627,0.70308757],"study_design_scores_gemma":[0.0039780037,0.00007864792,0.0005366987,0.00011029073,0.000052174037,0.0001445332,0.00021061237,0.4840361,0.00026634717,0.015171305,0.49501503,0.00040028404],"about_ca_topic_score_codex":0.00021021915,"about_ca_topic_score_gemma":0.000021218279,"teacher_disagreement_score":0.8004945,"about_ca_system_score_codex":0.0003087772,"about_ca_system_score_gemma":0.00048597582,"threshold_uncertainty_score":0.99993795},"labels":[],"label_agreement":null},{"id":"W2287309625","doi":"10.1007/s40290-015-0124-4","title":"The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Excellence; Transparency (behavior); Certification; Agency (philosophy); Business; Health care; Timeline; Medicine; Product (mathematics); Public relations; Political science; Sociology","score_opus":0.3241643169139876,"score_gpt":0.49964211922415575,"score_spread":0.17547780231016813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287309625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92152315,0.025281347,0.0000055783603,0.051581167,0.00007551662,0.0010772081,0.0000039796737,0.000008063413,0.0004439847],"genre_scores_gemma":[0.99674135,0.0015775061,0.000027706226,0.0014835716,0.00008750506,0.000039876224,0.000008003768,0.000009289589,0.000025177424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996913,0.0007776623,0.0006285663,0.00032365136,0.0010918863,0.00026524236],"domain_scores_gemma":[0.99821985,0.0005164668,0.0004211492,0.00020138304,0.00031988817,0.00032124892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006636063,0.00017886676,0.00045902043,0.000037761514,0.00009035791,0.000020378644,0.000099825134,0.00005286329,0.000008533782],"category_scores_gemma":[0.0033434632,0.00009909591,0.000010463758,0.000360148,0.0005235219,0.00020220113,0.000036742924,0.0006618342,1.028451e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025674077,0.00071595935,0.8675066,0.0108334,0.00019860614,0.000043797707,0.008209246,0.00003769045,0.0013560767,0.0017481414,0.0014630142,0.105320014],"study_design_scores_gemma":[0.04194721,0.004132692,0.7192779,0.04254226,0.0076086256,0.0011779884,0.029790748,0.1113371,0.005922038,0.010361539,0.024582934,0.0013189358],"about_ca_topic_score_codex":0.020398622,"about_ca_topic_score_gemma":0.19709384,"teacher_disagreement_score":0.17669523,"about_ca_system_score_codex":0.00013149768,"about_ca_system_score_gemma":0.0005023374,"threshold_uncertainty_score":0.98612463},"labels":[],"label_agreement":null},{"id":"W2342279036","doi":"10.1007/s40290-016-0142-x","title":"Content Related to Older Adults in Canadian Innovator–Drug Product Monographs: An Exploratory Analysis","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Innovator; Geriatrics; Notice; Product (mathematics); Population; Gerontology; Family medicine; Computer science; Environmental health; Psychiatry","score_opus":0.1531829746538198,"score_gpt":0.42332776015447854,"score_spread":0.27014478550065874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342279036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9122494,0.0011772304,0.000038163176,0.08347821,0.0005599113,0.0013831635,0.000028825454,0.00010752651,0.000977565],"genre_scores_gemma":[0.9812415,0.00028625687,0.000105523686,0.017591195,0.00019905336,0.00010709494,0.000054186963,0.00004168093,0.00037345517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962104,0.00030812054,0.0009525864,0.0008143802,0.00068078976,0.0010337413],"domain_scores_gemma":[0.994872,0.00037555446,0.00011589054,0.00059102266,0.00033719343,0.0037083633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016050212,0.00036932938,0.00084171357,0.0016576542,0.00006821356,0.000012280927,0.0002440155,0.00009885515,0.0036604695],"category_scores_gemma":[0.0018680195,0.00022386029,0.00013821192,0.0035878862,0.00025465942,0.0003940502,0.00006005035,0.00059073436,0.00023544412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019936124,0.00072895136,0.94522953,0.000120929224,0.0008564876,0.00050648965,0.0033024487,0.0000032703203,0.004707951,0.0005482804,0.0035105795,0.038491484],"study_design_scores_gemma":[0.033951536,0.001554999,0.6986525,0.0025506043,0.004946937,0.000109833134,0.0028415106,0.004360719,0.00951404,0.00015692382,0.23984464,0.0015157559],"about_ca_topic_score_codex":0.0104965875,"about_ca_topic_score_gemma":0.016042393,"teacher_disagreement_score":0.24657701,"about_ca_system_score_codex":0.0003502844,"about_ca_system_score_gemma":0.00027235577,"threshold_uncertainty_score":0.9972503},"labels":[],"label_agreement":null},{"id":"W2567239969","doi":"10.1007/s40290-016-0172-4","title":"The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Timeline; Food and drug administration; Regulatory affairs; Agency (philosophy); Medicine; Certificate; Business; Medical education; Political science; Public administration; Environmental health; Computer science; Sociology","score_opus":0.15703231075620758,"score_gpt":0.4712236755776073,"score_spread":0.31419136482139975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567239969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499317,0.0023047295,0.000044294797,0.045457598,0.00042796237,0.0004896037,0.00006948201,0.000032897256,0.0012417256],"genre_scores_gemma":[0.9969157,0.0010184756,0.00001345064,0.00080622424,0.00027918295,0.000042447497,0.000009998794,0.000014086506,0.0009004419],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829865,0.00018166784,0.00048125366,0.00031745192,0.0003403672,0.0003805928],"domain_scores_gemma":[0.9981146,0.00089188246,0.00025525715,0.00013661837,0.00018139693,0.000420253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005339684,0.00023441973,0.00032469686,0.000041478586,0.00038370566,0.000012350914,0.0001540024,0.000086994965,0.00018882669],"category_scores_gemma":[0.00019113024,0.00012722678,0.000019997706,0.0001807949,0.0009500693,0.000172031,0.000026496577,0.0004990875,0.0000028197853],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010804592,0.0016152599,0.2678172,0.0025616123,0.002262013,0.0002873119,0.0061681,0.00015422165,0.3483072,0.032448314,0.10239055,0.22518364],"study_design_scores_gemma":[0.009415624,0.0012024085,0.010027346,0.00050053163,0.0010793179,0.00031155784,0.0024578688,0.0016678394,0.44689408,0.0009224722,0.5248821,0.00063888915],"about_ca_topic_score_codex":0.0005444167,"about_ca_topic_score_gemma":0.018118104,"teacher_disagreement_score":0.42249152,"about_ca_system_score_codex":0.000057605885,"about_ca_system_score_gemma":0.0002846623,"threshold_uncertainty_score":0.99979866},"labels":[],"label_agreement":null},{"id":"W2615558757","doi":"10.1007/s40290-017-0191-9","title":"Myths and Realities About Why Prescription Drug Prices in the United States Are So High","year":2017,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Medical prescription; Drug; Medicine; Pharmacotherapy; Mythology; Drug prices; Environmental health; Political science; Family medicine; Traditional medicine; Pharmacology; Psychiatry; Public economics; Economics; History","score_opus":0.11022600024979189,"score_gpt":0.3562483066323625,"score_spread":0.2460223063825706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615558757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7400207,0.0075216675,0.00016948195,0.23184708,0.00079260423,0.0005136729,0.0002285677,0.00004432607,0.018861908],"genre_scores_gemma":[0.95639664,0.0129571855,0.000041878964,0.02988726,0.0004382567,0.000044244465,0.000042598662,0.000020143103,0.00017181737],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984736,0.000046301284,0.00060500466,0.00037613715,0.000065281325,0.00043369769],"domain_scores_gemma":[0.9986402,0.0003201932,0.0003538154,0.00044542964,0.000028340743,0.0002120439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013543292,0.00020650387,0.00044917193,0.00023444465,0.00038419786,0.00024642292,0.0005306696,0.00007152751,0.0003935994],"category_scores_gemma":[0.00045157812,0.00016065792,0.000041372707,0.000117157455,0.0007760411,0.00031011517,0.00012800905,0.00041967892,0.00007139183],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001832788,0.00021676783,0.05898045,0.000328688,0.00011334456,0.000037251673,0.007683188,0.000058368463,0.000037959184,0.88411283,0.0436376,0.004610263],"study_design_scores_gemma":[0.0020697427,0.0000482158,0.096060045,0.00008492452,0.000028533444,0.00000817533,0.00067287334,0.0154198455,0.000053153843,0.09118467,0.7941221,0.0002477514],"about_ca_topic_score_codex":0.004531271,"about_ca_topic_score_gemma":0.0001740647,"teacher_disagreement_score":0.79292816,"about_ca_system_score_codex":0.000055681452,"about_ca_system_score_gemma":0.000010325788,"threshold_uncertainty_score":0.68499565},"labels":[],"label_agreement":null},{"id":"W2941706251","doi":"10.1007/s40290-019-00278-z","title":"Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada)","funders":"Bayer","keywords":"Aflibercept; Medicine; Key (lock); Risk analysis (engineering); Intensive care medicine; Risk assessment; Surgery; Computer science; Chemotherapy","score_opus":0.08479523333586769,"score_gpt":0.39559780974420333,"score_spread":0.31080257640833564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941706251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908082,0.0012598464,0.00013228746,0.0005000442,0.0002927006,0.002735907,0.00009012928,0.0000035964692,0.0041773105],"genre_scores_gemma":[0.9995713,0.0000976865,0.000034304587,0.00009105019,0.000042801574,0.000047936574,0.00010283957,0.000007064076,0.0000050096282],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973819,0.0003477672,0.0006036674,0.00010561546,0.0014416954,0.00011931195],"domain_scores_gemma":[0.9973022,0.00024393313,0.00037182416,0.00019519606,0.001820064,0.000066790286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020896327,0.0001027198,0.00033580078,0.000090498295,0.000018705674,7.9435125e-7,0.00006876735,0.000035837624,0.00018508814],"category_scores_gemma":[0.001791575,0.00006546519,0.00006722761,0.00031443854,0.00007068947,0.00009185135,0.0000164729,0.00008243733,0.0000019074735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002349403,0.0006488919,0.16676372,0.0010824003,0.00037004144,9.905831e-8,0.0034831222,0.0063362904,0.0031222997,0.00039527664,0.00037617242,0.8150723],"study_design_scores_gemma":[0.013064217,0.00021215802,0.70007753,0.0006078684,0.0034694949,6.168264e-7,0.00070318836,0.27547356,0.0053566196,0.0003623417,0.0006128425,0.000059533144],"about_ca_topic_score_codex":0.022035405,"about_ca_topic_score_gemma":0.012458277,"teacher_disagreement_score":0.81501275,"about_ca_system_score_codex":0.00054882164,"about_ca_system_score_gemma":0.0015168351,"threshold_uncertainty_score":0.9844769},"labels":[],"label_agreement":null},{"id":"W2987745860","doi":"10.1007/s40290-019-00306-y","title":"Current Landscape of Late-Phase Clinical Trials for Alzheimer’s Disease: Comparing Regional Variation Between Subjects in Japan and North America","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"Clinical trial; Medicine; Clinical endpoint; Population; Observational study; Clinical Dementia Rating; Disease; Dementia; Internal medicine; Environmental health","score_opus":0.41007262536455885,"score_gpt":0.5541037621333915,"score_spread":0.14403113676883267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987745860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989431,0.003959037,0.00061038375,0.0035958092,0.00020171105,0.001986959,0.000031377465,0.000019167142,0.00016453303],"genre_scores_gemma":[0.99731,0.0012361268,0.0000733117,0.00039972123,0.0005443396,0.000065080974,0.00033547866,0.000015042677,0.000020896226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973404,0.00042846982,0.0010095893,0.0003674782,0.00051952305,0.00033456294],"domain_scores_gemma":[0.99646443,0.002434422,0.0002048184,0.0001527551,0.00017191525,0.00057166367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028731436,0.00016091364,0.0010154599,0.00018027202,0.000027474047,0.0000064994174,0.0000810968,0.000047226607,0.00033455473],"category_scores_gemma":[0.0016136238,0.0001171206,0.00011650027,0.00026792925,0.00022344352,0.000064948006,0.000055111886,0.00035353974,0.000013315288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00346952,0.00061522383,0.8601205,0.00030872153,0.0001951973,0.0000050362773,0.00012698029,0.0000010682919,0.0002822544,0.000051096995,0.0004312315,0.1343932],"study_design_scores_gemma":[0.026572116,0.0015121216,0.94921285,0.00040311762,0.001234963,0.0000015020411,0.0000616613,0.012339409,0.00007720353,0.000102131155,0.008372034,0.000110917514],"about_ca_topic_score_codex":0.000011485007,"about_ca_topic_score_gemma":0.0000019272245,"teacher_disagreement_score":0.13428229,"about_ca_system_score_codex":0.0000186532,"about_ca_system_score_gemma":0.00012501655,"threshold_uncertainty_score":0.47760394},"labels":[],"label_agreement":null},{"id":"W3010852553","doi":"10.1007/s40290-020-00329-w","title":"US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Adverse Event Reporting System; Food and drug administration; Adverse effect; Medicine; Drug; Food safety; Environmental health; Emergency medicine; Pharmacology","score_opus":0.20345642122992655,"score_gpt":0.47564872300221445,"score_spread":0.2721923017722879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010852553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8709638,0.0017668105,0.0007059941,0.11855467,0.001549841,0.0013274192,0.00005952613,0.00032245752,0.004749503],"genre_scores_gemma":[0.9796595,0.00050480594,0.00009425014,0.018015511,0.001452181,0.0000857934,0.00002366957,0.000030289846,0.00013400443],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958034,0.00037373125,0.002272465,0.0006369183,0.0003580264,0.0005554164],"domain_scores_gemma":[0.99632764,0.00063772907,0.0015901368,0.00020362317,0.00012919962,0.0011116522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030846107,0.00034447247,0.00060641463,0.00007075866,0.00069643767,0.00002167706,0.00018403959,0.00012794603,0.00020868825],"category_scores_gemma":[0.003573981,0.00024829668,0.00009109417,0.00040024347,0.00037164104,0.00019838462,0.0001841701,0.0011492627,0.000041534677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013125958,0.0010509539,0.2602055,0.0063677183,0.0036935832,0.0048552095,0.056846417,0.006538004,0.29135197,0.024822844,0.08289948,0.24824235],"study_design_scores_gemma":[0.004123437,0.0005541844,0.0064385533,0.00027462744,0.0012670296,0.0009808474,0.00863958,0.02542506,0.029565891,0.000055033357,0.92207426,0.0006014804],"about_ca_topic_score_codex":0.000017797951,"about_ca_topic_score_gemma":0.000013025169,"teacher_disagreement_score":0.8391748,"about_ca_system_score_codex":0.00008817939,"about_ca_system_score_gemma":0.00011194376,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W3042380614","doi":"10.1007/s40290-020-00345-w","title":"Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Université du Québec à Trois-Rivières","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Postmarketing surveillance; Adverse drug reaction; Data quality; Pharmacoepidemiology; Descriptive statistics; Drug; Pharmacology; Database; Adverse effect; Business; Marketing; Computer science; Statistics","score_opus":0.7319876051940398,"score_gpt":0.5953530109512966,"score_spread":0.13663459424274327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042380614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85486346,0.0041211164,0.00025153861,0.111316174,0.004994198,0.009669793,0.008458084,0.00055209314,0.0057735504],"genre_scores_gemma":[0.97153527,0.00016920318,0.00014513836,0.022628576,0.0047446247,0.00013719816,0.00048299023,0.00008231263,0.0000746677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903736,0.0044705607,0.001063095,0.0015040601,0.0009458181,0.0016428259],"domain_scores_gemma":[0.98454124,0.011253997,0.00023248198,0.001022888,0.0006823107,0.0022670801],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012251845,0.0005513871,0.00080797693,0.0001557443,0.0028633066,0.00007708903,0.0024438836,0.00022752833,0.0017655118],"category_scores_gemma":[0.004982243,0.00041297294,0.00013974025,0.0010057103,0.00094771566,0.00028786366,0.00061654794,0.0035179479,0.00023604961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07691604,0.006045224,0.13114843,0.0021841088,0.0068585845,0.012641013,0.034544013,0.005952808,0.33807802,0.0012817751,0.34533688,0.03901311],"study_design_scores_gemma":[0.011672731,0.00029312624,0.0017331623,0.00018554687,0.0018635034,0.0002100304,0.012566496,0.26999485,0.0022722513,0.000037833343,0.6984893,0.0006811232],"about_ca_topic_score_codex":0.022135098,"about_ca_topic_score_gemma":0.019145433,"teacher_disagreement_score":0.35315245,"about_ca_system_score_codex":0.001020505,"about_ca_system_score_gemma":0.0011491701,"threshold_uncertainty_score":0.9998322},"labels":[],"label_agreement":null},{"id":"W3121676279","doi":"10.1007/s40290-020-00370-9","title":"Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019","year":2021,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Public Health Ontario; McMaster University; University of Toronto","funders":"","keywords":"Enforcement; Revenue; Promotion (chess); Advertising; Business; Medical prescription; Food and drug administration; Prescription drug; Medicine; Marketing; Accounting; Environmental health; Pharmacology; Political science; Law","score_opus":0.3513951824707327,"score_gpt":0.5601475269582138,"score_spread":0.2087523444874811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121676279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89850456,0.009709667,0.0026518141,0.0781854,0.0028486296,0.0008525101,0.0010311084,0.00018367426,0.0060326634],"genre_scores_gemma":[0.96693295,0.001051287,0.0004066799,0.029092431,0.00096808246,0.00005499114,0.0005980829,0.000034202738,0.0008612983],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515486,0.0009377643,0.0013038308,0.00084244134,0.0006805629,0.0010805456],"domain_scores_gemma":[0.9953607,0.0018646717,0.0002296065,0.0004764515,0.00023721045,0.0018313848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012984114,0.00045550845,0.0011205975,0.0005735376,0.0003012377,0.000017939956,0.00042187324,0.0003347309,0.039676514],"category_scores_gemma":[0.00053374516,0.00042014653,0.00030821378,0.0022663237,0.00045464264,0.00017532328,0.00023672229,0.0018114689,0.00016287825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003022682,0.0019769685,0.25330892,0.00036379942,0.013149305,0.00093765155,0.005211807,0.015623215,0.5028029,0.006223158,0.12785411,0.06952544],"study_design_scores_gemma":[0.007985433,0.00020476806,0.055761814,0.000408288,0.018713167,0.000034940545,0.0009935467,0.05933492,0.14639068,0.00041003412,0.70862955,0.001132848],"about_ca_topic_score_codex":0.00037748303,"about_ca_topic_score_gemma":0.00031534166,"teacher_disagreement_score":0.58077544,"about_ca_system_score_codex":0.0002574085,"about_ca_system_score_gemma":0.00016372894,"threshold_uncertainty_score":0.99982506},"labels":[],"label_agreement":null},{"id":"W3193700822","doi":"10.1007/s40290-021-00397-6","title":"The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic","year":2021,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Authorization; Pandemic; Coronavirus disease 2019 (COVID-19); Medical emergency; 2019-20 coronavirus outbreak; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Business; Computer security; Virology; Infectious disease (medical specialty); Disease; Outbreak; Computer science","score_opus":0.4623289032833736,"score_gpt":0.5408226501648542,"score_spread":0.07849374688148059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193700822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004551145,0.9936346,0.00024476947,0.0020204328,0.0010774201,0.0019048484,0.000025313115,0.000099833735,0.0005377034],"genre_scores_gemma":[0.00090406387,0.98727065,0.000011182184,0.010349499,0.000836731,0.00021403917,0.00002268741,0.00007564071,0.00031550447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99397093,0.0014625315,0.0017158127,0.00082757376,0.0012831342,0.00074001035],"domain_scores_gemma":[0.99348426,0.004317908,0.00042940807,0.0009214151,0.0003510196,0.00049596815],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037857052,0.0005899893,0.0020309808,0.00023055275,0.00035721832,0.000018552535,0.0005144745,0.0003706714,0.00062210066],"category_scores_gemma":[0.0115952445,0.00029859244,0.00043442834,0.00083931285,0.0019284196,0.000089309855,0.00040135704,0.002097299,0.000017778733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047060053,0.00027628485,0.0073046978,0.050866574,0.001109199,0.00024419627,0.00057847454,3.8093187e-8,0.00078543165,0.0011166009,0.009397782,0.9278501],"study_design_scores_gemma":[0.0015537937,0.00008736308,0.00009721444,0.0022897888,0.0031197052,0.00056534004,0.0000924683,0.00021918397,0.000051583487,0.000045656954,0.9916318,0.0002460665],"about_ca_topic_score_codex":0.00010664996,"about_ca_topic_score_gemma":0.000012545981,"teacher_disagreement_score":0.98223406,"about_ca_system_score_codex":0.0009899623,"about_ca_system_score_gemma":0.0017175942,"threshold_uncertainty_score":0.9999466},"labels":[],"label_agreement":null},{"id":"W3203314040","doi":"10.1007/s40290-021-00402-y","title":"How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream","year":2021,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Pandemic; Drug development; Mainstream; Pharmacovigilance; Public health; Medicine; Coronavirus disease 2019 (COVID-19); Pharmaceutical industry; Procurement; Business; Public relations; Political science; Drug; Economic growth; Pharmacology; Disease; Infectious disease (medical specialty); Marketing","score_opus":0.24169205724386084,"score_gpt":0.4934767466812031,"score_spread":0.2517846894373423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203314040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023119373,0.9080252,0.00022337705,0.08778301,0.0005265776,0.0022007304,0.000013034539,0.00014453077,0.0008523181],"genre_scores_gemma":[0.00069116696,0.86637527,0.00008331012,0.1303419,0.001612017,0.00048280298,0.0000777165,0.00007256422,0.0002632451],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99401325,0.0010009547,0.0010389391,0.0011180843,0.0017075706,0.0011212205],"domain_scores_gemma":[0.9950008,0.002579791,0.000267712,0.0010688202,0.00028530095,0.0007976117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031475846,0.00090587453,0.0025480373,0.00021738937,0.00057486957,0.0001878033,0.0009824308,0.0003699645,0.00016245517],"category_scores_gemma":[0.004357204,0.00040196005,0.0003587569,0.0018462611,0.0010214692,0.00010126684,0.0008790206,0.0022829731,0.000054632237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007341717,0.0001398766,0.002452844,0.010947235,0.0008995368,0.0005375909,0.00053542043,4.3793804e-9,0.0000074640457,0.0008768113,0.010039639,0.9734902],"study_design_scores_gemma":[0.0028850571,0.000089305635,0.000028328117,0.0040196595,0.0021168198,0.002761744,0.0004992,0.000024259498,0.000012456848,0.00013802668,0.98704207,0.00038306948],"about_ca_topic_score_codex":0.00009442438,"about_ca_topic_score_gemma":0.00017027478,"teacher_disagreement_score":0.97700244,"about_ca_system_score_codex":0.00174471,"about_ca_system_score_gemma":0.004338894,"threshold_uncertainty_score":0.99984324},"labels":[],"label_agreement":null},{"id":"W4242306480","doi":"10.1093/med/9780199609147.003.0012","title":"Health Canada","year":2013,"lang":"en","type":"book-chapter","venue":"Pharmaceutical Medicine","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.17063958525648087,"score_gpt":0.5016619708817266,"score_spread":0.3310223856252457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242306480","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020389452,0.009735635,0.000018566156,0.3140877,0.003929554,0.0011604842,0.000073036324,0.000106047155,0.67088693],"genre_scores_gemma":[0.00025188288,0.004647903,0.00004934696,0.38277793,0.0031052772,0.000063845924,0.00015618358,0.00008525928,0.60886234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562734,0.00019990643,0.0014892932,0.000525388,0.000937231,0.0012208166],"domain_scores_gemma":[0.99559397,0.0014964547,0.0005305896,0.0005489322,0.0002725617,0.001557501],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00073421316,0.0005182546,0.0015312043,0.00013905737,0.0006176715,0.000002305446,0.00036646263,0.0004347434,0.09831979],"category_scores_gemma":[0.00019534836,0.00038460628,0.00008147177,0.000047021756,0.00020830223,0.000047563935,0.00020585762,0.003437842,0.0031026772],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023949513,0.0000047261774,0.000077209676,0.0013051647,0.00005716396,0.000035857374,0.00012172481,2.8483997e-8,0.0000012625867,0.0692478,0.88682115,0.042303942],"study_design_scores_gemma":[0.0011787061,0.0001055933,0.00020719116,0.00090236304,0.00008281541,0.0000063794205,0.00004689744,0.000009214809,3.96122e-7,0.0042759986,0.9928904,0.00029403644],"about_ca_topic_score_codex":0.45820397,"about_ca_topic_score_gemma":0.39653116,"teacher_disagreement_score":0.10606923,"about_ca_system_score_codex":0.0035416826,"about_ca_system_score_gemma":0.014703368,"threshold_uncertainty_score":0.9998606},"labels":[],"label_agreement":null},{"id":"W4308697730","doi":"10.1007/s40290-022-00447-7","title":"The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes","year":2022,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada)","funders":"","keywords":"Clinical trial; Medicine; Cannabis; Synthetic cannabinoids; Randomized controlled trial; Drug development; Drug; Cannabinoid; Pharmacology; Psychiatry; Internal medicine","score_opus":0.6472075699016272,"score_gpt":0.6247242841693867,"score_spread":0.022483285732240454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308697730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008902139,0.95145506,0.000014729514,0.03463689,0.0012335087,0.012037465,0.00038177724,0.000023729735,0.0002079406],"genre_scores_gemma":[0.0000062687277,0.9826897,0.00005198637,0.0028494427,0.0013334577,0.0038677135,0.00025366276,0.000112614034,0.008835171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9792852,0.0069423527,0.010408137,0.00084084,0.0017899193,0.0007335974],"domain_scores_gemma":[0.9769862,0.014870206,0.0051260255,0.0011350448,0.00085171673,0.0010307676],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07370947,0.00076856225,0.014478892,0.00033903358,0.00025130555,0.000017191058,0.00060223415,0.0002872905,0.0020066614],"category_scores_gemma":[0.09229465,0.0003426056,0.0017335227,0.0007198224,0.0011713941,0.000025891346,0.00025488329,0.0015921219,0.000003333214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019962515,0.00027534334,0.0000034851546,0.16978866,0.0012202365,0.00001809595,0.000057224228,2.7181e-9,0.0000024582023,0.00019353675,0.1389544,0.6874903],"study_design_scores_gemma":[0.0036026838,0.0017529898,0.00002698245,0.07867096,0.009210851,0.00007688758,0.0000615571,0.0000057984944,0.000025893001,0.000017039176,0.9062653,0.00028303312],"about_ca_topic_score_codex":0.00003296764,"about_ca_topic_score_gemma":0.0000059258336,"teacher_disagreement_score":0.7673109,"about_ca_system_score_codex":0.00022791311,"about_ca_system_score_gemma":0.0049614185,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W4317391044","doi":"10.1007/s40290-022-00459-3","title":"Digital Therapies (DTx) as New Tools within Physicians’ Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep Edouard Montpetit; Université de Montréal; Simon Fraser University","funders":"","keywords":"Psychological intervention; Intervention (counseling); Digital health; Engineering ethics; Medicine; Business; Risk analysis (engineering); Public relations; Political science; Health care; Engineering; Nursing","score_opus":0.23723856907933674,"score_gpt":0.458602792905748,"score_spread":0.22136422382641127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317391044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604153,0.0004916248,0.0003286601,0.032506734,0.00096721115,0.001397345,0.00006709575,0.0002819669,0.00354403],"genre_scores_gemma":[0.97714406,0.000023404915,0.00030758165,0.01091674,0.00016853644,0.00025572962,0.0000686057,0.0000497473,0.011065602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812776,0.00013194504,0.0004939231,0.00047624012,0.00027905003,0.00049109093],"domain_scores_gemma":[0.9975518,0.0014581421,0.0000804198,0.00023066411,0.00006500687,0.0006139397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004705442,0.00027012156,0.00034537268,0.00023064132,0.00015995203,0.00012493083,0.00014124576,0.00006931575,0.00019584897],"category_scores_gemma":[0.00038710935,0.00020936063,0.00004321326,0.0006334949,0.00026504052,0.0004612046,0.00013304087,0.00026052288,0.00050423434],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008279121,0.00028599697,0.005338643,0.00008470799,0.0003773591,0.000066694534,0.024967413,0.0000014933805,0.0017743304,0.027629843,0.008815307,0.9298303],"study_design_scores_gemma":[0.00578562,0.0043977224,0.41416094,0.0011032186,0.0001743768,0.00014592127,0.0084051285,0.00013513958,0.008256727,0.020814937,0.5358075,0.00081277685],"about_ca_topic_score_codex":0.000035668436,"about_ca_topic_score_gemma":0.00002287269,"teacher_disagreement_score":0.92901754,"about_ca_system_score_codex":0.00006946577,"about_ca_system_score_gemma":0.00010174048,"threshold_uncertainty_score":0.85374784},"labels":[],"label_agreement":null},{"id":"W4372333015","doi":"10.1007/s40290-023-00474-y","title":"Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Embedding; Medicine; Disease; Ecosystem; Pharmacotherapy; Intensive care medicine; Internal medicine; Computer science; Biology; Ecology; Artificial intelligence","score_opus":0.0118236033157068,"score_gpt":0.2962372390432417,"score_spread":0.28441363572753486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372333015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348176,0.0006339431,0.00019482826,0.0041512586,0.00021285939,0.0006992049,0.00036850024,0.000030114246,0.00022755585],"genre_scores_gemma":[0.9968032,0.00012629874,0.000017586808,0.002246388,0.00019242767,0.00007832851,0.00044010338,0.000024857158,0.0000708043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987978,0.000058461577,0.0002164381,0.00030731552,0.0002780514,0.00034194833],"domain_scores_gemma":[0.99910694,0.000039810693,0.000043701402,0.00019674677,0.00013444622,0.0004783392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012779619,0.00016393342,0.00014508326,0.000036408328,0.0001800828,0.000017736294,0.00016892579,0.00003491145,0.0000389969],"category_scores_gemma":[0.00018708415,0.000094743,0.000037302776,0.00035648546,0.000056196153,0.00000343045,0.0000685341,0.00007947377,0.000021864687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008153488,0.0015990428,0.17106748,0.0012365653,0.0008917462,0.0004322397,0.0035204608,0.005231783,0.11518086,0.0002445897,0.56442326,0.12801848],"study_design_scores_gemma":[0.0076742545,0.0021772985,0.010461843,0.00037839144,0.00045233875,0.000012053924,0.002458136,0.011245846,0.034167085,0.000051187373,0.92995536,0.00096619537],"about_ca_topic_score_codex":0.0000046807836,"about_ca_topic_score_gemma":0.0000065988547,"teacher_disagreement_score":0.3655321,"about_ca_system_score_codex":0.000021772259,"about_ca_system_score_gemma":0.00005616953,"threshold_uncertainty_score":0.38635075},"labels":[],"label_agreement":null},{"id":"W4377221230","doi":"10.1007/s40290-023-00478-8","title":"Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fondation Pierre Fabre","keywords":"Pharmacovigilance; Medicine; Pharmacotherapy; Traditional medicine; Pharmacology; Drug; Psychiatry","score_opus":0.2678028493135785,"score_gpt":0.44213186868439086,"score_spread":0.17432901937081235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377221230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8695695,0.07853189,0.0000618968,0.045557242,0.0007325521,0.00065228756,0.00010193415,0.00013672811,0.0046559605],"genre_scores_gemma":[0.9326858,0.06584234,0.00003767161,0.0008186369,0.00052238716,0.00002995066,0.000033827844,0.000022121516,0.00000726131],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969488,0.00016227989,0.00094937114,0.00040561246,0.00093688426,0.0005970901],"domain_scores_gemma":[0.9973693,0.0015919046,0.00020441673,0.00017697069,0.00019303487,0.0004643585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013926488,0.00026712386,0.0009016515,0.00045679638,0.00004666015,0.0000036569602,0.00013698325,0.00007635129,0.00046381602],"category_scores_gemma":[0.0008241747,0.00021364234,0.000067210145,0.0007364614,0.0012356784,0.0001273659,0.00008042733,0.0005661877,0.0000100487805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004333219,0.0027569367,0.30082443,0.036376283,0.00077259645,0.0006034048,0.027589303,0.000042208016,0.08806061,0.078417145,0.0023975729,0.4578263],"study_design_scores_gemma":[0.02881367,0.0020518287,0.7043957,0.012532785,0.0013362628,0.00021374854,0.007034754,0.017726365,0.02576601,0.006325777,0.19288185,0.0009212438],"about_ca_topic_score_codex":0.000056415192,"about_ca_topic_score_gemma":0.000014465414,"teacher_disagreement_score":0.45690504,"about_ca_system_score_codex":0.00006541859,"about_ca_system_score_gemma":0.00012564896,"threshold_uncertainty_score":0.8712082},"labels":[],"label_agreement":null},{"id":"W4400475270","doi":"10.1007/s40290-024-00529-8","title":"Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials","year":2024,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Generalizability theory; Inclusion (mineral); Clinical trial; Diversity (politics); Equity (law); Medicine; Disease; Relevance (law); Management science; Psychology; Pathology; Political science","score_opus":0.4169885344615545,"score_gpt":0.6002199609442508,"score_spread":0.1832314264826963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400475270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025068852,0.9948273,0.000012007073,0.0005622456,0.0007194967,0.0008833239,0.00020736532,0.000017795666,0.0002636391],"genre_scores_gemma":[0.04088382,0.9563031,0.00001803192,0.00069935404,0.0015055765,0.000029251429,0.00047048068,0.000038263952,0.00005210186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948713,0.0019963158,0.0014676842,0.00096508634,0.0003499219,0.0003496575],"domain_scores_gemma":[0.99776304,0.0006498826,0.0002511576,0.00041374913,0.000057983914,0.0008641789],"candidate_categories":["metaepi_narrow","open_science"],"consensus_categories":[],"category_scores_codex":[0.0085537,0.0004383788,0.0019909507,0.00015313643,0.00019967859,0.000038799895,0.00057762145,0.000359236,0.0000956918],"category_scores_gemma":[0.006924355,0.00028400205,0.00048298782,0.00016553448,0.00044549443,0.000004761502,0.022938896,0.0005789386,0.000011640081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003030462,0.00017725177,0.001817411,0.01267728,0.00020565031,0.0003287994,0.000026808644,5.1744e-8,0.000013401836,0.000040049454,0.0021117283,0.9822985],"study_design_scores_gemma":[0.0013621047,0.0001247358,0.00053789304,0.008022598,0.0051817195,0.00005712402,0.000014668375,0.00005357478,0.0000015635499,0.0018764986,0.9823244,0.00044309194],"about_ca_topic_score_codex":0.000027712213,"about_ca_topic_score_gemma":0.0000095278,"teacher_disagreement_score":0.98185545,"about_ca_system_score_codex":0.000053299642,"about_ca_system_score_gemma":0.00039261393,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4411639738","doi":"10.1007/s40290-025-00573-y","title":"Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators","year":2025,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; University of Sydney","keywords":"Pharmacology; Medicine; Environmental health; Business","score_opus":0.1384110428210106,"score_gpt":0.4996191888193955,"score_spread":0.3612081459983849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411639738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76515746,0.0048255543,0.0009252664,0.13319513,0.008234147,0.0028094633,0.00013814474,0.0002690168,0.08444582],"genre_scores_gemma":[0.9803712,0.00054187706,0.000022679324,0.017585944,0.000427355,0.00007015112,0.00001907558,0.000019263205,0.00094245345],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689454,0.00060743635,0.00097648444,0.00036456564,0.0007070151,0.00044996754],"domain_scores_gemma":[0.99079436,0.007924841,0.0003823461,0.00025287314,0.00038964348,0.00025592675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015999075,0.00033066428,0.00078783545,0.00033096797,0.0002581877,0.0000032831772,0.0004997118,0.00022382884,0.0016049575],"category_scores_gemma":[0.00260166,0.00021717373,0.00017332534,0.00087107485,0.0013059542,0.00008231001,0.00010376992,0.0014520319,0.000043332562],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004542184,0.0025611522,0.030522201,0.0020530436,0.0023850675,0.00005566499,0.0049318005,0.0012691015,0.5763021,0.081458695,0.25284946,0.041069496],"study_design_scores_gemma":[0.008964029,0.00041381197,0.0055380412,0.00095178303,0.0013231321,0.000016601063,0.00076257973,0.019658858,0.46005142,0.0031458172,0.49887243,0.00030150832],"about_ca_topic_score_codex":0.000016654823,"about_ca_topic_score_gemma":0.0000020990517,"teacher_disagreement_score":0.24602297,"about_ca_system_score_codex":0.00013342248,"about_ca_system_score_gemma":0.00020623574,"threshold_uncertainty_score":0.9993077},"labels":[],"label_agreement":null},{"id":"W4416741600","doi":"10.1093/med/9780198842255.003.0015","title":"Health Canada","year":2025,"lang":"en","type":"book-chapter","venue":"Pharmaceutical Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Clinical trial; Drug; Pharmacotherapy; MEDLINE; Public health; Drug trial","score_opus":0.5064515909366728,"score_gpt":0.5088575807551402,"score_spread":0.0024059898184674022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416741600","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000024438002,0.032291662,0.00054977956,0.41816717,0.0023763808,0.00065451674,0.0005546132,0.000051530853,0.5453519],"genre_scores_gemma":[0.0014411741,0.0037067072,0.0003317568,0.33847344,0.0024026525,0.000049404174,0.00026542984,0.00008635842,0.65324306],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99256474,0.00013030041,0.005569441,0.0008514189,0.00025180174,0.0006323122],"domain_scores_gemma":[0.99456155,0.0018049385,0.0021342298,0.00065147335,0.00008473437,0.000763063],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008853093,0.0004511172,0.0026210428,0.00037331574,0.00018580812,0.000016491975,0.00042894916,0.000259606,0.008959495],"category_scores_gemma":[0.0027132302,0.0005235426,0.00012171963,0.00007279806,0.00020299008,0.00008084966,0.00009826309,0.00084734446,0.0012508422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006127495,0.000007367182,0.0000688313,0.000674742,0.000086905384,0.0000043214322,0.000059213533,0.0000014901975,3.586011e-8,0.45356086,0.54392606,0.0016040243],"study_design_scores_gemma":[0.00081461907,0.000059550715,0.000082822,0.0008981624,0.000024725023,0.000006834544,0.0000315747,0.00057693454,3.273109e-7,0.03877047,0.95837957,0.00035441172],"about_ca_topic_score_codex":0.21663421,"about_ca_topic_score_gemma":0.118676,"teacher_disagreement_score":0.4147904,"about_ca_system_score_codex":0.0026808965,"about_ca_system_score_gemma":0.0022559564,"threshold_uncertainty_score":0.9997216},"labels":[],"label_agreement":null},{"id":"W4416837248","doi":"10.1007/s40290-025-00593-8","title":"Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biosimilar; Pharmacovigilance; New product development; Product (mathematics); Key (lock); MEDLINE; Drug development","score_opus":0.23519607778497048,"score_gpt":0.5185248198969498,"score_spread":0.2833287421119793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416837248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.03483755e-8,0.9873013,0.00055748556,0.0054505374,0.0012446216,0.00426941,0.000112363276,0.000052782958,0.0010115202],"genre_scores_gemma":[4.9572895e-7,0.9910878,0.0011573544,0.0063039437,0.00025186577,0.0006744149,0.00016125158,0.000023529577,0.0003393231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965501,0.0008171505,0.0014324446,0.00061759487,0.00006604287,0.00051667757],"domain_scores_gemma":[0.99206275,0.0071755657,0.00024788693,0.00031363507,0.00012328094,0.00007685589],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017687624,0.00046128864,0.0028325606,0.0004121802,0.000109748005,0.000008017783,0.00021581007,0.0006518074,0.00216077],"category_scores_gemma":[0.00676569,0.0003151144,0.0004027376,0.0006807882,0.00033642797,0.000035775647,0.00010087042,0.00092109793,0.000046432335],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012887615,0.000085785774,0.0000014873995,0.35125348,0.000106429856,0.000008316328,0.000005764948,1.6145819e-8,0.000006374902,0.0013222155,0.026487116,0.62071013],"study_design_scores_gemma":[0.00067912735,0.000076373515,2.733902e-7,0.36354795,0.0033464374,0.000029930909,0.0000026564692,0.0000014639625,0.0000064979076,0.00023763774,0.6318633,0.00020837333],"about_ca_topic_score_codex":0.0000027495537,"about_ca_topic_score_gemma":0.0000048844054,"teacher_disagreement_score":0.62050176,"about_ca_system_score_codex":0.000093748706,"about_ca_system_score_gemma":0.000489741,"threshold_uncertainty_score":0.9999301},"labels":[],"label_agreement":null},{"id":"W48989372","doi":"10.1007/bf03256677","title":"Drug Approval Times and User Fees","year":2008,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Government (linguistics); Business; Agency (philosophy); Approved drug; Drug; Payment; User fee; Finance; Drug approval; Resource (disambiguation); Orphan drug; Public economics; Medicine; Pharmacology; Economics","score_opus":0.10931244738849398,"score_gpt":0.3302034876115756,"score_spread":0.2208910402230816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48989372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57438964,0.025729215,0.00095937,0.09242645,0.0014855998,0.0006404282,0.0001234595,0.0002278579,0.304018],"genre_scores_gemma":[0.97813016,0.0044898666,0.00038130485,0.012859771,0.0007901703,0.000022164912,0.000009113189,0.000034147008,0.0032832911],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.998402,0.000021766033,0.0006011615,0.0004589773,0.000051426403,0.0004646947],"domain_scores_gemma":[0.99893665,0.00019100888,0.000116085954,0.00021885618,0.000020395146,0.0005169784],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005009905,0.00022033745,0.00053516554,0.00017206985,0.00016157042,0.000016319518,0.00020855656,0.0000723441,0.0033496036],"category_scores_gemma":[0.0001933353,0.00020901828,0.000066661254,0.00017073343,0.0006289909,0.0001722554,0.00011109378,0.00033690786,0.0009487564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011850854,0.00022475401,0.056953076,0.000118704906,0.0001785476,0.00006462248,0.0012854412,0.000009132183,0.0003069952,0.80616987,0.12963592,0.004934454],"study_design_scores_gemma":[0.0023305384,0.000059042886,0.0076095406,0.000016490028,0.000021880767,0.00010746801,0.000030596337,0.006931934,0.0004498573,0.023824219,0.9582787,0.0003397306],"about_ca_topic_score_codex":0.00008801797,"about_ca_topic_score_gemma":0.0000018645197,"teacher_disagreement_score":0.8286428,"about_ca_system_score_codex":0.000045823967,"about_ca_system_score_gemma":0.000016730008,"threshold_uncertainty_score":0.9998291},"labels":[],"label_agreement":null},{"id":"W53859789","doi":"10.1007/bf03256848","title":"A Proposed Framework for Formulary Listing in Low-Income Countries","year":2011,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Formulary; Listing (finance); Psychological intervention; High income countries; Actuarial science; Medicine; Health care; Developing country; Business; Public economics; Family medicine; Economic growth; Economics; Finance; Nursing","score_opus":0.5612886048884482,"score_gpt":0.5196973706371593,"score_spread":0.04159123425128897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W53859789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34511617,0.01906742,0.3352236,0.2577058,0.0060132765,0.009040153,0.00045910184,0.00048337833,0.026891103],"genre_scores_gemma":[0.9551006,0.00017104953,0.019190209,0.024164075,0.0009437557,0.00022795559,0.00001549801,0.000046026133,0.00014086277],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9954854,0.00014035332,0.0031798673,0.00048708584,0.000107826134,0.0005994537],"domain_scores_gemma":[0.9959375,0.002576294,0.00079264713,0.0003204019,0.00007107673,0.0003020441],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012752783,0.00020662251,0.0009850531,0.00031611545,0.00012449155,0.00001690515,0.00028026543,0.00017123969,0.0015837131],"category_scores_gemma":[0.011869987,0.00021853304,0.000075534634,0.00023142739,0.0002089429,0.00028942217,0.000047903428,0.0003432266,0.00050416176],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020398047,0.00014462117,0.10595752,0.0021771546,0.00005904775,0.000008068561,0.0058490066,0.000006198292,0.0000045082584,0.8835954,0.0016005748,0.0003939057],"study_design_scores_gemma":[0.008450346,0.0006467068,0.054130014,0.003179753,0.00005489088,0.000020102294,0.0016035654,0.049638208,0.00023789138,0.78339124,0.09761416,0.0010331284],"about_ca_topic_score_codex":0.00027001282,"about_ca_topic_score_gemma":0.000026582931,"teacher_disagreement_score":0.6099844,"about_ca_system_score_codex":0.00033176193,"about_ca_system_score_gemma":0.00008390222,"threshold_uncertainty_score":0.999329},"labels":[],"label_agreement":null}]}